Evidence map›Paper›PMID 24150839›Full record

ArticleCurrent infectious disease reports2013

Does the nose know? An update on MRSA decolonization strategies.

C L Abad, M S Pulia, N Safdar

Open access · greenAbstract read
In one paragraph

Article in Current infectious disease reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Distribution ofFrontiers in cellular and infection microbiology · 2025
    Article
  3. Biofilm Producing Methicillin-ResistantPathogens (Basel, Switzerland) · 2024
    Review
  4. Article
  5. Randomized controlled trial of chlorhexidine gluconate, intranasal mupirocin, rifampin, and doxycycline versus chlorhexidine gluconate and intranasal mupirocin alone for the eradication of methicillin-resistantJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2021
    Article
  6. Article
  7. Article
  8. Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Review
  9. Article
  10. Article
  11. Article
  12. MRSA decolonization failure-are biofilms the missing link?Antimicrobial resistance and infection control · 2017
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Screening of methicillin-resistantJournal of laboratory physicians
    Article
  19. Methicillin-ResistantIndian journal of nephrology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

C L AbadSection of Infectious Diseases, Department of Medicine, The Medical City, Pasig City, Philippines.
M S Pulia
N Safdar
University of Wisconsin–Madison · USUniversity of Asia and the Pacific · PH

Funding

Probiotics to Improve Outcomes of Clostridium difficileR03AG040669 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI SAFDAR, NASIA · 2012 to 2013
$146k
NIA NIH HHS R03 AG040669
6 · The paper itself

Abstract

Colonization with methicillin-resistant Staphylococcus aureus (MRSA) is an important step in the pathogenesis of active infection and is a key factor in the epidemiology of MRSA infection. Decolonization of patients found to have MRSA carriage may be of value in certain patient populations, especially those undergoing elective surgery. However, the most commonly used agent for decolonization, mupirocin, comes with a considerable risk of resistance if widely employed. Recent studies of other novel agents for decolonization show promise, but further research is necessary. This review focuses on the pathogenesis from MRSA colonization to infection, identifies the risk factors for colonization, and summarizes decolonization strategies, including novel approaches that may have a role in decreasing MRSA disease burden.

Identifiers

PMID24150839
PMCPMC4258870
OpenAlexW2043207418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.